Correction to: Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials

Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/2447

Title:	Correction to: Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials
Authors:	Merchant, T. E. Indelicato, D. J. Onar-Thomas, A. Ellison, D. W. Boop, F. A. Robinson, G. W. Gajjar, A. Northcott, P. A. Liu, A. P. Y. Gudenas, B. Lin, T. Orr, B. A. Klimo, P., Jr. Kumar, R. Bouffet, E. Gururangan, S. Crawford, J. R. Kellie, S. J. Chintagumpala, M. Fisher, M. J. Bowers, D. C. Hassall, T.
Issue Date:	2020
Source:	Feb 139, (2), 2020, p. 273-275
Pages:	273-275
Journal:	Acta Neuropathol
Abstract:	The original version of this article unfortunately contained a typesetting error in Fig 3c. The corrected Fig. 3 is given in the following page.1432-0533Liu, Anthony P Y Orcid: 0000-0002-8597-9128 Gudenas, Brian Lin, Tong Orr, Brent A Klimo, Paul Jr Kumar, Rahul Bouffet, Eric Gururangan, Sridharan Crawford, John R Kellie, Stewart J Chintagumpala, Murali Fisher, Michael J Bowers, Daniel C Hassall, Tim Indelicato, Daniel J Onar-Thomas, Arzu Ellison, David W Boop, Frederick A Merchant, Thomas E Robinson, Giles W Northcott, Paul A Gajjar, Amar P30 CA021765/CA/NCI NIH HHS/United States Journal Article Published Erratum Germany Acta Neuropathol. 2020 Feb;139(2):273-275. doi: 10.1007/s00401-019-02115-8.
DOI:	10.1007/s00401-019-02115-8
Type:	Article
Appears in Sites:	Children's Health Queensland Publications

36

checked on Mar 18, 2025

Check